Skip to main content
. 2019 Aug 20;9:79. doi: 10.1186/s13550-019-0546-1

Fig. 1.

Fig. 1

Percentage variation (right panels) or absolute value (left panels) for bone marrow uptake between baseline and interim PET/CT, depending on the metabolic active tumour volume (MATV) on baseline scan (a), the type of G-CSF (b), and the time-lapse between the last injection of chemotherapy and the PET/CT examination (c)